Doug Lauffenburger
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Douglas A. Lauffenburger is an American academic who is the Ford Professor of Biological Engineering, Chemical Engineering, and Biology at the Massachusetts Institute of Technology (since 2009). He is a member of the David H. Koch Institute for Integrative Cancer Research and MIT Center for Gynepathology Research as well as an Affiliate, The Ragon Institute of MIT, MGH and Harvard.[1] He is also editor in chief of the journal Integrative Biology.[2]
Lauffenburger’s lab “emphasizes integration of experimental and mathematical/computational analysis approaches, toward development and validation of predictive models for physiologically-relevant behavior in terms of underlying molecular and molecular network properties.”[3]
Biography
Lauffenburger earned a B.S. in Chemical Engineering from the University of Illinois and a Ph.D. in Chemical Engineering from the University of Minnesota.[1]
Lauffenburger was a professor at the University of Illinois and the University of Pennsylvania and a visiting professor at the University of Wisconsin before his tenure at MIT. He was a visiting scientist at the University of Heidelberg in Germany.[1]
At MIT, he has been a Professor at the Department of Biological Engineering since 1998 and was then Head, 1998-2019; Professor, Department of Chemical Engineering, 1995-present; Professor, Department of Biology, 2002-present.[4][5]
References
- ^ a b c "Douglas A. Lauffenburger, PhD". Biological Engineering. MIT. Retrieved 19 November 2020.
- ^ "Integrative Biology". Oxford University Press. Retrieved 19 November 2020.
- ^ "Doug Lauffenburger Research Group". MIT. Retrieved 19 November 2020.
- ^ "Doug Lauffenburger : Research Group". MIT. Retrieved 19 November 2020.
- ^ Zhong, Vivian (April 18, 2019). "Doug Lauffenburger reflects on time as inaugural biological engineering department head". The Tech. Retrieved 19 November 2020.